TAGRISSO 80 mg/1 80 mg/1 TABLET, FILM COATED

TAGRISSO 80 mg/1

Active Ingredient:
osimertinib
Form:
TABLET, FILM COATED
Brand:
TAGRISSO
Origin:
USA

Buy TAGRISSO 80 mg/1 osimertinib

TAGRISSO 80 mg is a medication used in cancer treatment. It contains osimertinib, a targeted therapy for specific genetic mutations. Learn more about its uses and effects.

Strength

80 mg/1

Pack Size

30 TABLET, FILM COATED in 1 BOTTLE (0310-1350-30)

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Uses / Indications

  • TAGRISSO 80 mg is primarily used in the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations. This medication targets the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. It is often prescribed for patients who have developed resistance to other EGFR-targeted therapies. What is TAGRISSO used for? It is used to manage advanced NSCLC in patients with EGFR T790M mutation-positive tumors.

Side Effects

  • Common effects of TAGRISSO 80 mg may include diarrhea, rash, dry skin, and nail problems. Some users may experience fatigue, cough, or changes in appetite. These effects vary among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

  • TAGRISSO 80 mg should be handled with care. Store it at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Follow the prescribed dosage and administration instructions provided by your healthcare provider.

Avoid Interactions

  • TAGRISSO 80 mg may interact with certain medications, including those that are metabolized by the liver's CYP3A enzyme. Always inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions.

References

Frequently Asked Questions

TAGRISSO is used to treat non-small cell lung cancer (NSCLC) with specific EGFR mutations, particularly in patients who have developed resistance to other EGFR-targeted therapies.

TAGRISSO is typically taken orally, usually once daily. Follow the specific instructions provided by your healthcare provider.

Common side effects may include diarrhea, rash, dry skin, and fatigue. Always consult your healthcare provider for personalized advice.

TAGRISSO may interact with certain medications. Inform your healthcare provider about all medications you are taking to avoid potential interactions.

Store TAGRISSO at room temperature away from moisture and heat. Keep it out of reach of children and pets.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT